Page last updated: 2024-08-25

beta-hydroxyisovaleric acid and Squamous Cell Carcinoma of Head and Neck

beta-hydroxyisovaleric acid has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Higaki, Y; Kunitake, N; Kuroki, K; Masuda, M; Rikimaru, F; Toh, S1

Trials

1 trial(s) available for beta-hydroxyisovaleric acid and Squamous Cell Carcinoma of Head and Neck

ArticleYear
Efficacy of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine for the prevention of mucositis induced by platinum-based chemoradiation in head and neck cancer: A phase II study.
    Clinical nutrition ESPEN, 2023, Volume: 57

    Topics: Arginine; Cachexia; Chemoradiotherapy; Glutamine; Head and Neck Neoplasms; Humans; Mucositis; Squamous Cell Carcinoma of Head and Neck

2023